Clinical Trial Update: Study of Bortezomib in Combination With Cyclophosphamide and Rituximab [Phase 2]

View source ↗

Summary

Phase 2 study of bortezomib in combination with cyclophosphamide and rituximab in mantle cell lymphoma and other lymphomas has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Rituxan (rituximab)
• Velcade (bortezomib) (bortezomib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Mantle Cell Lymphoma, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2015-04-13